Over the last 7 days, the Healthtech industry has dropped 2.9%, driven by Veeva Systems declining 3.0%. In contrast, SOPHiA GENETICS has gained 17%. This takes the industry's 12 month performance to a gain of 32%. Earnings are forecast to grow by 23% annually.
Has the U.S. Healthtech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 13 Jul 2025 | US$76.9b | US$13.2b | -US$1,382,394,447.00 | 54.2x | -55.7x | 5.8x |
Tue, 10 Jun 2025 | US$78.7b | US$13.2b | -US$1,382,393,022.00 | 57.4x | -56.9x | 5.9x |
Thu, 08 May 2025 | US$69.0b | US$13.2b | -US$1,324,722,959.00 | 67.3x | -52.1x | 5.2x |
Sat, 05 Apr 2025 | US$65.5b | US$13.2b | -US$1,414,656,089.00 | 48.7x | -46.3x | 5x |
Mon, 03 Mar 2025 | US$71.6b | US$13.1b | -US$1,576,934,514.00 | 65.7x | -45.4x | 5.5x |
Wed, 29 Jan 2025 | US$69.3b | US$12.9b | -US$1,638,054,514.00 | 58.9x | -42.3x | 5.4x |
Fri, 27 Dec 2024 | US$67.3b | US$12.9b | -US$1,636,315,514.00 | 55.2x | -41.1x | 5.2x |
Sun, 24 Nov 2024 | US$64.5b | US$12.8b | -US$1,712,780,390.00 | 54.3x | -37.7x | 5x |
Tue, 22 Oct 2024 | US$66.3b | US$13.9b | -US$3,264,548,151.00 | 53.8x | -20.3x | 4.8x |
Thu, 19 Sep 2024 | US$66.0b | US$14.0b | -US$3,302,096,821.00 | 54.5x | -20x | 4.7x |
Sat, 17 Aug 2024 | US$60.0b | US$13.9b | -US$3,380,458,127.00 | 56.7x | -17.7x | 4.3x |
Mon, 15 Jul 2024 | US$57.8b | US$13.7b | -US$1,860,692,542.00 | 51.8x | -31.1x | 4.2x |
Wed, 12 Jun 2024 | US$59.0b | US$13.7b | -US$1,889,950,216.00 | 47.7x | -31.2x | 4.3x |
Fri, 10 May 2024 | US$56.7b | US$12.6b | -US$2,000,355,742.00 | 50.2x | -28.3x | 4.5x |
Sun, 07 Apr 2024 | US$61.1b | US$12.7b | -US$1,616,515,745.00 | 51.3x | -37.8x | 4.8x |
Tue, 05 Mar 2024 | US$64.7b | US$14.1b | -US$1,435,324,794.00 | 49.3x | -45.1x | 4.6x |
Thu, 01 Feb 2024 | US$73.1b | US$18.3b | -US$5,780,316,752.00 | 58.9x | -12.7x | 4x |
Sat, 30 Dec 2023 | US$73.3b | US$18.3b | -US$5,781,192,665.00 | 58.4x | -12.7x | 4x |
Mon, 27 Nov 2023 | US$65.9b | US$18.2b | -US$5,807,346,665.00 | 52.5x | -11.3x | 3.6x |
Wed, 25 Oct 2023 | US$67.1b | US$18.0b | -US$5,559,240,965.00 | 52.3x | -12.1x | 3.7x |
Fri, 22 Sep 2023 | US$69.5b | US$18.0b | -US$5,514,972,389.00 | 51.1x | -12.6x | 3.9x |
Sun, 20 Aug 2023 | US$69.7b | US$17.9b | -US$5,554,149,562.00 | 55.2x | -12.5x | 3.9x |
Tue, 18 Jul 2023 | US$80.2b | US$17.7b | -US$8,580,548,318.00 | 62.7x | -9.3x | 4.5x |
Thu, 15 Jun 2023 | US$74.8b | US$17.7b | -US$8,581,046,209.00 | 61.4x | -8.7x | 4.2x |
Sat, 13 May 2023 | US$70.2b | US$17.6b | -US$8,602,278,065.00 | 57.2x | -8.2x | 4x |
Mon, 10 Apr 2023 | US$72.3b | US$17.4b | -US$14,978,932,055.00 | 55.5x | -4.8x | 4.1x |
Wed, 08 Mar 2023 | US$73.2b | US$17.7b | -US$15,417,568,105.00 | 55.2x | -4.8x | 4.1x |
Fri, 03 Feb 2023 | US$77.6b | US$17.5b | -US$10,804,200,563.00 | 55x | -7.2x | 4.4x |
Sun, 01 Jan 2023 | US$94.8b | US$35.5b | -US$8,887,710,310.00 | 34x | -10.7x | 2.7x |
Tue, 29 Nov 2022 | US$71.6b | US$17.4b | -US$10,605,197,310.00 | 44.3x | -6.7x | 4.1x |
Thu, 27 Oct 2022 | US$68.9b | US$17.1b | -US$10,571,067,342.00 | 35x | -6.5x | 4x |
Sat, 24 Sep 2022 | US$70.6b | US$17.1b | -US$10,593,627,342.00 | 30.9x | -6.7x | 4.1x |
Mon, 22 Aug 2022 | US$84.2b | US$17.0b | -US$10,450,720,342.00 | 33.8x | -8.1x | 4.9x |
Wed, 20 Jul 2022 | US$92.2b | US$17.4b | -US$7,974,433,542.00 | 62.6x | -11.6x | 5.3x |
-11.6x
How does U.S. Healthtech compare with similar industries?
US Market | -0.51% | |
Healthcare | -0.27% | |
Healthtech | -2.88% | |
Healthtech | -2.88% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
SOPH SOPHiA GENETICS | US$3.49 | 16.7% +US$33.4m | -25.1% | PS3.5x | |
PTHL Pheton Holdings | US$21.01 | 9.7% +US$26.5m | n/a | PS668x | |
CTEV Claritev | US$46.32 | 2.0% +US$14.6m | 197.5% | PS0.8x | |
GDRX GoodRx Holdings | US$4.75 | 0.7% +US$13.3m | -38.5% | PE63.3x | |
TDOC Teladoc Health | US$8.32 | 0.4% +US$5.3m | -11.4% | PS0.6x |